Alex G. Howarth serves as Executive at AKCEA THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Alex G. Howarth has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 23, 2024 involved receiving (via award) 4,803 shares valued at $0.
Alex G. Howarth currently holds 18,737 shares of AKCEA THERAPEUTICS, INC. (AKCA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alex G. Howarth has been a net neutral trader of AKCA stock. They have purchased $0 and sold $0 worth of shares.
Alex G. Howarth's most recent insider trade was on Jan 23, 2024, when they sold 4,803 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $243.92 |
| Discretionary |
| Jan 16, 2023 | MDGL | $0 | Award | 15,001 | $N/A | Discretionary |
| Oct 12, 2020 | AKCA | $1.2M | Tender | 66,800 | $18.15 | Discretionary |
| Mar 19, 2020 | AKCA | $0 | Award | 16,800 | $N/A | Discretionary |
| Dec 2, 2019 | AKCA | $0 | Award | 50,000 | $N/A | Discretionary |